Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| CD9-H5222 | Human | Human CD69 / CLEC2C Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Triclabendazole | EGA-230B; CGA-89317; NVP-EGA230 | Approved | Novartis Pharma Ag | Egaten, Fasinex, Triclathera | United States | Fascioliasis | Novartis Pharma Ag | 1989-01-01 | Fascioliasis | Details |
| Decitabine/Cedazuridine | ASTX-727; E-7727/decitabine; Decitabine/E7727 | Approved | Astex Pharmaceuticals Inc | Inqovi | United States | Myelodysplastic Syndromes | Otsuka Pharmaceutical Co Ltd | 2020-07-07 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Leukemia; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Leukemia, Myeloid, Acute; Glioma; Nervous System Neoplasms; Neurilemmoma | Details |
| Mecobalamin | E-0302 | Approved | Myelogen, Naso B12, NASOCOBAL, Methycobal, 弥尔神, 悦敏兴, RHINOCOBAL, 奇信, 曲力, 弥可保 | Peripheral Nervous System Diseases; Autistic Disorder; Neuralgia; Neuritis; Vitamin B 12 Deficiency; Amyotrophic Lateral Sclerosis; Fibromyalgia | Details | |||||
| Decitabine | DAC; AzadC; E-7373; 5-aza-CdR; NSC-127716 | Approved | Eisai Co Ltd | 达珂, Dacogen | EU | Leukemia, Myeloid, Acute | Janssen-Cilag International Nv | 2006-05-02 | Burkitt Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Breast Neoplasms; Neuroblastoma; Primary Myelofibrosis; Colorectal Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma; Urinary Bladder Neoplasms; Lung Neoplasms; Thyroid Neoplasms; Precancerous Conditions; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Thyroid Cancer, Papillary; Breast Neoplasms, Male; Melanoma; Anemia, Sickle Cell; Lymphoma, Large B-Cell, Diffuse; Solid tumours; Leukemia; Purpura, Thrombocytopenic, Idiopathic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Leukemia, Myeloid, Accelerated Phase; Leukemia, Promyelocytic, Acute; Esophageal Neoplasms; Thalassemia; Neutropenia; Myelodysplastic Syndromes; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Immunoblastic; Plasmacytoma; Small Cell Lung Carc | Details |
| Azacitidine | NSC-102816; 5-aza-CR; CC-486; NS-17; U-18496; NEX-18; NEX-18a | Approved | Celgene Corp | 维达莎, Vidaza, Onureg | United States | Leukemia, Myeloid, Acute | Celgene Corp | 2004-05-19 | Leukemia, Myeloid, Acute; Immune System Diseases; Prostatic Neoplasms; Tuberculosis, Pulmonary; Breast Neoplasms; Osteosarcoma; Sarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Brain Neoplasms; Primary Myelofibrosis; Hepatic Insufficiency; Multiple Myeloma; Lymphoma; Lung Neoplasms; Leukemia, Myelomonocytic, Juvenile; Thyroid Neoplasms; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Myelodysplastic-Myeloproliferative Diseases; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Large Granular Lymphocytic; Myelodysplastic Syndromes; Head and Neck Neoplasms; Intestinal Neoplasms; Solid tumours; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Ependymoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Leukemia, Myelomonocytic, Chronic; Leukemia; beta-Thalassemia; Lymphoma, Large B-Cell, Diffuse; Plasmacytoma; Myeloproliferative Disorders; Neoplasms; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Hodgkin Disea | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| FdCyd | NSC-48006; Ro-5-1090 | Phase 2 Clinical | City Of Hope National Medical Center, National Cancer Institute | Head and Neck Neoplasms; Esophageal Neoplasms; Neoplasms; Myelodysplastic Syndromes; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
| Azacitidine/Cedazuridine | ASTX-030 | Phase 3 Clinical | Otsuka Pharmaceutical Co Ltd | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
| Decitabine/Tetrahydrouridine | EPI-01 | Phase 2 Clinical | Epicdestiny | Anemia, Sickle Cell | Details |
| Curcumin | VOLT-03; VOLT-3; NSC-32982 | Phase 3 Clinical | University Of Pennsylvania | Renal Insufficiency, Chronic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Breast Neoplasms; Oral Submucous Fibrosis; Tobacco Use Disorder; Cardiovascular Diseases; Cognitive Dysfunction; Neuralgia; Colorectal Neoplasms; Cervical Intraepithelial Neoplasia; Uterine Cervical Dysplasia; Cigarette Smoking; Asthma; Chronic Periodontitis; Lung Neoplasms; Lichen Planus, Oral; Adenocarcinoma, Mucinous; Inflammation; Osteoarthritis; Uterine Cervical Neoplasms; Aortic Aneurysm, Abdominal; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Adenocarcinoma; Neoplasm Metastasis; Macular Degeneration; Neoplasms; Drug-Related Side Effects and Adverse Reactions; Adenomatous Polyposis Coli; Optic Atrophy, Hereditary, Leber; Digestive System Diseases; Depression; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2; Gastritis, Atrophic; Radiodermatitis; Pain; Spasm; Rectal Neoplasms; Atherosclerosis; Primary Dysautonomias; Arthritis, Rheumatoid; Spondylitis, An | Details |
| Guadecitabine Sodium | SGI-110; S-110; 0RB89YH367 (UNII code) | Phase 2 Clinical | Otsuka Holdings Co Ltd | Klatskin Tumor; Adenocarcinoma; Paraganglioma; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Peritoneal Neoplasms; Cholangiocarcinoma; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Myeloproliferative Disorders; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Stomach Neoplasms; Carcinoma, Renal Cell; Pheochromocytoma; Kidney Neoplasms; Chondrosarcoma | Details |
| EF-009 | EF-009 | Phase 2 Clinical | Everfront Biotech Co Ltd | Pancreatic Neoplasms | Details |
| NTX-301 | NTX-303 | Phase 2 Clinical | Southern Research Institute, Pinotbio Inc | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
